These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31328429)

  • 21. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
    Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
    J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.
    Case KK; Gomez GB; Hallett TB
    J Int AIDS Soc; 2019 Sep; 22(9):e25390. PubMed ID: 31538407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP Communications Accelerator: a digital demand creation tool for sub-Saharan Africa.
    Schwartz K; Ferrigno B; Vining S; Gomez A; Briedenhann E; Gardiner E; Jeckonia P; Torjesen K
    Sex Health; 2018 Nov; 15(6):570-577. PubMed ID: 30408430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.
    Koechlin FM; Fonner VA; Dalglish SL; O'Reilly KR; Baggaley R; Grant RM; Rodolph M; Hodges-Mameletzis I; Kennedy CE
    AIDS Behav; 2017 May; 21(5):1325-1335. PubMed ID: 27900502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.
    Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influences of geo-spatial location on pre-exposure prophylaxis use in South Africa: positioning microbicides for better product uptake.
    Govender EM; Mansoor LE; Abdool Karim Q
    AIDS Care; 2017 Jun; 29(6):734-740. PubMed ID: 27799005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Webb EL; Tshabalala G; Hornschuh S; Mulaudzi M; Atujuna M; Stranix-Chibanda L; Nematadzira T; Ssemata AS; Muhumuza R; Seeley J; Bekker LG; Weiss HA; Martinson N; Fox J;
    J Int AIDS Soc; 2022 Aug; 25(8):e25975. PubMed ID: 36002910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
    BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A; Nakyanzi A; Kasiita V; Kamusiime B; Nalukwago GK; Nalumansi A; Twesigye CC; Muwonge TR; Baeten JM; Wyatt MA; Haberer JE; Ware NC
    J Int AIDS Soc; 2021 Sep; 24(9):e25782. PubMed ID: 34473405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
    Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
    AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.
    Mack N; Evens EM; Tolley EE; Brelsford K; Mackenzie C; Milford C; Smit JA; Kimani J
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19157. PubMed ID: 25224616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding PrEP Acceptability Among Priority Populations: Results from a Qualitative Study of Potential Users in Central Uganda.
    Sundararajan R; Wyatt MA; Muwonge TR; Pisarski EE; Mujugira A; Haberer JE; Ware NC
    AIDS Behav; 2022 Aug; 26(8):2676-2685. PubMed ID: 35133529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP.
    Fonner VA; Ntogwisangu J; Hamidu I; Joseph J; Fields J; Evans E; Kilewo J; Bailey C; Goldsamt L; Fisher CB; O'Reilly KR; Ruta T; Mbwambo J; Sweat MD
    BMC Public Health; 2021 Apr; 21(1):720. PubMed ID: 33853559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined HIV Adolescent Prevention Study (CHAPS): comparison of HIV pre-exposure prophylaxis regimens for adolescents in sub-Saharan Africa-study protocol for a mixed-methods study including a randomised controlled trial.
    Nash S; Dietrich J; Ssemata AS; Herrera C; O'Hagan K; Else L; Chiodi F; Kelly C; Shattock R; Chirenje M; Lebina L; Khoo S; Bekker LG; Weiss HA; Gray C; Stranix-Chibanda L; Kaleebu P; Seeley J; Martinson N; Fox J;
    Trials; 2020 Oct; 21(1):900. PubMed ID: 33121503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review.
    Vanhamel J; Rotsaert A; Reyniers T; Nöstlinger C; Laga M; Van Landeghem E; Vuylsteke B
    BMC Health Serv Res; 2020 Jul; 20(1):704. PubMed ID: 32736626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Policymakers' and healthcare providers' perspectives on the introduction of oral pre-exposure prophylaxis for key populations in Ghana.
    Nagai H; Adiibokah E; Tagoe H; Tun W; Pilgrim NA; Ankomah A; Rahman YAA; Addo SA; Atuahene SK; Essandoh E; Maher S; Kowalski M
    BMC Public Health; 2023 Jun; 23(1):1065. PubMed ID: 37277772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-Uninfected Kenyan Adolescent and Young Women Share Perspectives on Using Pre-Exposure Prophylaxis During Pregnancy.
    Pintye J; Beima-Sofie KM; Makabong'O PA; Njoroge A; Trinidad SB; Heffron RA; Baeten JM; Celum C; Matemo D; Kinuthia J; Kelley MC; John-Stewart GC
    AIDS Patient Care STDS; 2018 Dec; 32(12):538-544. PubMed ID: 30036072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.